Search

Your search keyword '"Atul T. Patel"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Atul T. Patel" Remove constraint Author: "Atul T. Patel"
78 results on '"Atul T. Patel"'

Search Results

1. SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication

2. Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis

Catalog

Books, media, physical & digital resources

3. Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults

4. AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

5. Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

7. AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol

8. Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX study

9. IncobotulinumtoxinA Treatment in Upper‐Limb Poststroke Spasticity in the Open‐Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life

10. Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

12. Upper Limb Orthotic Devices

13. Contributors

14. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study

15. Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study

17. Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study (Preprint)

20. Contributors

21. Development of the Hygiene Extension Limb Position Pain (HELP) tool to monitor waning of clinical efficacy in patients with spasticity or cervical dystonia treated with botulinum toxins

22. Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study

23. Poster 69: Safety and Efficacy of High‐Dose OnabotulinumtoxinA for Post‐Stroke Upper Limb Spasticity: Results of a Double‐Blind, Placebo‐Controlled Trial

24. Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience

25. Efficacy of incobotulinumtoxinA in upper-limb spasticity following stroke: results from the open-label extension period of pure

26. Immunogenicity of daxibotulinumtoxinA for injection in adults with cervical dystonia from a phase 2 dose-escalation multicenter study

27. The patients' perspective on botulinum neurotoxin type A treatment: Results of a multinational survey for patients with spasticity

29. Outcomes of week-24 completers and subjects who had follow-up beyond week 24 after a single treatment of daxibotulinumtoxinA for injection (RT002): Results of a phase 2, open-label (Level II), dose-escalating study in isolated cervical dystonia

30. Abstract TMP42: Safety and Efficacy of High-dose OnabotulinumtoxinA for Post-stroke Upper Limb Spasticity: Results of a Double-blind, Placebo-controlled Trial

31. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach

32. The American Academy of Orthopaedic Surgeons Evidence-Based Clinical Practice Guideline on: Management of Carpal Tunnel Syndrome

33. Poster 361 Impact of Early Intervention with OnabotulinumtoxinA Treatment in Adult Patients with Post-Stroke Lower Limb Spasticity

34. Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post‐Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm

35. Hypothermia-Induced Peripheral Polyneuropathy After an Episode of Drowning

36. Spasticity Video Challenge: A Look at Methods for Addressing Difficult Cases

38. Methodology of a phase 2, randomized, double-blind, placebo-controlled, parallel group, dose-ranging, 36-week, multicenter trial to evaluate the efficacy and safety of daxibotulinumtoxinA for injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury

39. Poster 52: Botulinum Toxin A in Upper Limb Spasticity Management: Baseline Data from the Upper Limb International Spasticity (ULIS)-III Study

40. An examination of real-world onabotulinumtoxina utilization for the treatment of lower limb spasticity: The Adult Spasticity International Registry (ASPIRE) study

41. Comparison of onabotulinumtoxina utilization across various etiologies of spasticity from the Adult spasticity international registry study: ASPIRE

42. Impact of spasticity and botulinum toxin-A injections on the daily life of patients and their caregivers: Results from an international online survey

43. 2010 Fatigue SAE-P Questions

44. 2009 SAE-P: Rehabilitation of Stroke and Neurodegenerative Disorders

45. OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process

46. Neck Pain and Cervical Dystonia: Treatment Outcomes from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)

48. 2005 SAE-P: Neuromuscular rehabilitation and electrodiagnosis

49. Impact of early intervention with onabotulinumtoxinA treatment in adult patients with poststroke lower limb spasticity

50. Randomized, Placebo-Controlled, Phase III Study of Incobotulinumtoxina for Upper-Limb Post-Stroke Spasticity